235 related articles for article (PubMed ID: 21917727)
1. F2-dihomo-isoprostanes as potential early biomarkers of lipid oxidative damage in Rett syndrome.
De Felice C; Signorini C; Durand T; Oger C; Guy A; Bultel-Poncé V; Galano JM; Ciccoli L; Leoncini S; D'Esposito M; Filosa S; Pecorelli A; Valacchi G; Hayek J
J Lipid Res; 2011 Dec; 52(12):2287-2297. PubMed ID: 21917727
[TBL] [Abstract][Full Text] [Related]
2. F(2)-Dihomo-isoprostanes and brain white matter damage in stage 1 Rett syndrome.
Durand T; De Felice C; Signorini C; Oger C; Bultel-Poncé V; Guy A; Galano JM; Leoncini S; Ciccoli L; Pecorelli A; Valacchi G; Hayek J
Biochimie; 2013 Jan; 95(1):86-90. PubMed ID: 23009927
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress in Rett syndrome: natural history, genotype, and variants.
Leoncini S; De Felice C; Signorini C; Pecorelli A; Durand T; Valacchi G; Ciccoli L; Hayek J
Redox Rep; 2011; 16(4):145-53. PubMed ID: 21888765
[TBL] [Abstract][Full Text] [Related]
4. Major metabolite of F2-isoprostane in urine may be a more sensitive biomarker of oxidative stress than isoprostane itself.
Dorjgochoo T; Gao YT; Chow WH; Shu XO; Yang G; Cai Q; Rothman N; Cai H; Li H; Deng X; Franke A; Roberts LJ; Milne G; Zheng W; Dai Q
Am J Clin Nutr; 2012 Aug; 96(2):405-14. PubMed ID: 22760572
[TBL] [Abstract][Full Text] [Related]
5. Potential applications of lipid peroxidation products - F
De Las Heras-Gómez I; Medina S; Casas-Pina T; Marín-Soler L; Tomás A; Martínez-Hernández P; Oger C; Galano JM; Durand T; Jimeno L; Llorente S; Lozoya E; Ferreres F; Gil-Izquierdo Á
Free Radic Biol Med; 2017 Mar; 104():178-184. PubMed ID: 28089724
[TBL] [Abstract][Full Text] [Related]
6. F2-dihomo-isoprostanes arise from free radical attack on adrenic acid.
VanRollins M; Woltjer RL; Yin H; Morrow JD; Montine TJ
J Lipid Res; 2008 May; 49(5):995-1005. PubMed ID: 18250368
[TBL] [Abstract][Full Text] [Related]
7. Dihomo-isoprostanes-nonenzymatic metabolites of AdA-are higher in epileptic patients compared to healthy individuals by a new ultrahigh pressure liquid chromatography-triple quadrupole-tandem mass spectrometry method.
Medina S; Miguel-Elízaga ID; Oger C; Galano JM; Durand T; Martínez-Villanueva M; Castillo ML; Villegas-Martínez I; Ferreres F; Martínez-Hernández P; Gil-Izquierdo Á
Free Radic Biol Med; 2015 Feb; 79():154-63. PubMed ID: 25464272
[TBL] [Abstract][Full Text] [Related]
8. Morphological changes and oxidative damage in Rett Syndrome erythrocytes.
Ciccoli L; De Felice C; Paccagnini E; Leoncini S; Pecorelli A; Signorini C; Belmonte G; Valacchi G; Rossi M; Hayek J
Biochim Biophys Acta; 2012 Apr; 1820(4):511-20. PubMed ID: 22183031
[TBL] [Abstract][Full Text] [Related]
9. Obesity, age, and oxidative stress in middle-aged and older women.
Dorjgochoo T; Gao YT; Chow WH; Shu XO; Yang G; Cai Q; Rothman N; Cai H; Li H; Deng X; Shrubsole MJ; Murff H; Milne G; Zheng W; Dai Q
Antioxid Redox Signal; 2011 Jun; 14(12):2453-60. PubMed ID: 21043829
[TBL] [Abstract][Full Text] [Related]
10. F₄-neuroprostanes mediate neurological severity in Rett syndrome.
Signorini C; De Felice C; Leoncini S; Giardini A; D'Esposito M; Filosa S; Della Ragione F; Rossi M; Pecorelli A; Valacchi G; Ciccoli L; Hayek J
Clin Chim Acta; 2011 Jul; 412(15-16):1399-406. PubMed ID: 21530498
[TBL] [Abstract][Full Text] [Related]
11. Assessment of oxidative stress biomarkers - neuroprostanes and dihomo-isoprostanes - in the urine of elite triathletes after two weeks of moderate-altitude training.
García-Flores LA; Medina S; Cejuela R; Martínez-Sanz JM; Oger C; Galano JM; Durand T; Casas-Pina T; Martínez-Hernández P; Ferreres F; Gil-Izquierdo Á
Free Radic Res; 2016; 50(5):485-94. PubMed ID: 26503242
[TBL] [Abstract][Full Text] [Related]
12. Intra-person variation of urinary biomarkers of oxidative stress and inflammation.
Wu X; Cai H; Xiang YB; Cai Q; Yang G; Liu D; Sanchez S; Zheng W; Milne G; Shu XO
Cancer Epidemiol Biomarkers Prev; 2010 Apr; 19(4):947-52. PubMed ID: 20332256
[TBL] [Abstract][Full Text] [Related]
13. Quantification of urinary F2-isoprostanes with 4(RS)-F4t-neuroprostane as an internal standard using gas chromatography-mass spectrometry Application to polytraumatized patients.
Mas E; Michel F; Guy A; Bultel V; Falquet Y; Chardon P; Rossi JC; Cristol JP; Durand T
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Sep; 872(1-2):133-40. PubMed ID: 18706873
[TBL] [Abstract][Full Text] [Related]
14. Increased isoprostanoid levels in brain from murine model of Krabbe disease - Relevance of isoprostanes, dihomo-isoprostanes and neuroprostanes to disease severity.
Signorini C; Cardile V; Pannuzzo G; Graziano ACE; Durand T; Galano JM; Oger C; Leoncini S; Cortelazzo A; Lee JC; Hayek J; De Felice C
Free Radic Biol Med; 2019 Aug; 139():46-54. PubMed ID: 31100476
[TBL] [Abstract][Full Text] [Related]
15. Snapshot situation of oxidative degradation of the nervous system, kidney, and adrenal glands biomarkers-neuroprostane and dihomo-isoprostanes-urinary biomarkers from infancy to elderly adults.
García-Flores LA; Medina S; Martínez-Hernández P; Oger C; Galano JM; Durand T; Casas-Pina T; Ferreres F; Gil-Izquierdo Á
Redox Biol; 2017 Apr; 11():586-591. PubMed ID: 28110214
[TBL] [Abstract][Full Text] [Related]
16. Systemic oxidative stress in classic Rett syndrome.
De Felice C; Ciccoli L; Leoncini S; Signorini C; Rossi M; Vannuccini L; Guazzi G; Latini G; Comporti M; Valacchi G; Hayek J
Free Radic Biol Med; 2009 Aug; 47(4):440-8. PubMed ID: 19464363
[TBL] [Abstract][Full Text] [Related]
17. Unresolved issues in the analysis of F2-isoprostanes, F4-neuroprostanes, isofurans, neurofurans, and F2-dihomo-isoprostanes in body fluids and tissue using gas chromatography/negative-ion chemical-ionization mass spectrometry.
Yen HC; Wei HJ; Lin CL
Free Radic Res; 2015; 49(7):861-80. PubMed ID: 25812589
[TBL] [Abstract][Full Text] [Related]
18. Increased F3-Isoprostanes in the Canadian Inuit Population Could Be Cardioprotective by Limiting F2-Isoprostane Production.
Alkazemi D; Jackson RL; Chan HM; Kubow S
J Clin Endocrinol Metab; 2016 Sep; 101(9):3264-71. PubMed ID: 27192695
[TBL] [Abstract][Full Text] [Related]
19. Measurement of urinary F(2)-isoprostanes by gas chromatography-mass spectrometry is confounded by interfering substances.
Mas E; Barden A; Durand T; Galano JM; Croft KD; Mori TA
Free Radic Res; 2010 Feb; 44(2):191-8. PubMed ID: 19929242
[TBL] [Abstract][Full Text] [Related]
20. MECP2 Duplication Syndrome: Evidence of Enhanced Oxidative Stress. A Comparison with Rett Syndrome.
Signorini C; De Felice C; Leoncini S; Møller RS; Zollo G; Buoni S; Cortelazzo A; Guerranti R; Durand T; Ciccoli L; D'Esposito M; Ravn K; Hayek J
PLoS One; 2016; 11(3):e0150101. PubMed ID: 26930212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
